1. Home
  2. CASI vs CAPT Comparison

CASI vs CAPT Comparison

Compare CASI & CAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CASI
  • CAPT
  • Stock Information
  • Founded
  • CASI 1991
  • CAPT 2005
  • Country
  • CASI China
  • CAPT South Korea
  • Employees
  • CASI N/A
  • CAPT N/A
  • Industry
  • CASI Biotechnology: Pharmaceutical Preparations
  • CAPT Blank Checks
  • Sector
  • CASI Health Care
  • CAPT Finance
  • Exchange
  • CASI Nasdaq
  • CAPT Nasdaq
  • Market Cap
  • CASI 35.8M
  • CAPT 37.9M
  • IPO Year
  • CASI 1996
  • CAPT N/A
  • Fundamental
  • Price
  • CASI $2.01
  • CAPT $1.12
  • Analyst Decision
  • CASI Strong Buy
  • CAPT
  • Analyst Count
  • CASI 1
  • CAPT 0
  • Target Price
  • CASI $4.00
  • CAPT N/A
  • AVG Volume (30 Days)
  • CASI 76.1K
  • CAPT 161.9K
  • Earning Date
  • CASI 11-13-2025
  • CAPT 01-01-0001
  • Dividend Yield
  • CASI N/A
  • CAPT N/A
  • EPS Growth
  • CASI N/A
  • CAPT N/A
  • EPS
  • CASI N/A
  • CAPT N/A
  • Revenue
  • CASI $31,564,000.00
  • CAPT $17,389,944.00
  • Revenue This Year
  • CASI N/A
  • CAPT N/A
  • Revenue Next Year
  • CASI N/A
  • CAPT N/A
  • P/E Ratio
  • CASI N/A
  • CAPT N/A
  • Revenue Growth
  • CASI 36.64
  • CAPT 84.70
  • 52 Week Low
  • CASI $1.09
  • CAPT $0.37
  • 52 Week High
  • CASI $7.50
  • CAPT $2.60
  • Technical
  • Relative Strength Index (RSI)
  • CASI 50.04
  • CAPT 43.61
  • Support Level
  • CASI N/A
  • CAPT $1.02
  • Resistance Level
  • CASI $2.49
  • CAPT $1.21
  • Average True Range (ATR)
  • CASI 0.17
  • CAPT 0.08
  • MACD
  • CASI -0.14
  • CAPT 0.00
  • Stochastic Oscillator
  • CASI 80.40
  • CAPT 47.62

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

About CAPT Captivision Inc.

Captivision Inc Formerly Glaam Co Ltd is engaged in manufacturing, installing, and selling LED display G-Glass. G-Glass is an integrated ICT product that has the basic characteristics of transparent glass but can display media images at the same time. It implements media images through the glass surface while preserving the features of clear and transparent glass. G-Glass is the world's first IT building material that can be applied to various places where glass is used.

Share on Social Networks: